A detailed history of Alliancebernstein L.P. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 179,908 shares of SRPT stock, worth $17.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
179,908
Previous 219,010 17.85%
Holding current value
$17.5 Million
Previous $27.4 Million 20.03%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$104.54 - $137.94 $4.09 Million - $5.39 Million
-39,102 Reduced 17.85%
179,908 $21.9 Million
Q3 2024

Nov 14, 2024

BUY
$124.33 - $156.75 $576,766 - $727,163
4,639 Added 2.16%
219,010 $27.4 Million
Q2 2024

Aug 14, 2024

SELL
$113.33 - $163.85 $11.8 Million - $17 Million
-103,866 Reduced 32.64%
214,371 $33.9 Million
Q1 2024

May 14, 2024

BUY
$93.7 - $141.53 $5.84 Million - $8.82 Million
62,326 Added 24.35%
318,237 $41.2 Million
Q4 2023

Feb 14, 2024

SELL
$67.31 - $124.76 $14.7 Million - $27.2 Million
-217,741 Reduced 45.97%
255,911 $24.7 Million
Q3 2023

Nov 14, 2023

SELL
$102.5 - $123.59 $2.83 Million - $3.42 Million
-27,649 Reduced 5.52%
473,652 $57.4 Million
Q2 2023

Aug 15, 2023

BUY
$106.4 - $157.19 $1.18 Million - $1.74 Million
11,069 Added 2.26%
501,301 $57.4 Million
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $44.8 Million - $59.5 Million
381,524 Added 350.96%
490,232 $67.6 Million
Q4 2022

Feb 14, 2023

SELL
$100.86 - $132.13 $3.12 Million - $4.08 Million
-30,901 Reduced 22.13%
108,708 $14.1 Million
Q3 2022

Nov 15, 2022

SELL
$75.71 - $119.24 $6.09 Million - $9.59 Million
-80,467 Reduced 36.56%
139,609 $15.4 Million
Q2 2022

Aug 15, 2022

SELL
$62.69 - $88.44 $2.19 Million - $3.09 Million
-34,988 Reduced 13.72%
220,076 $16.5 Million
Q1 2022

May 13, 2022

BUY
$63.15 - $90.42 $9.45 Million - $13.5 Million
149,631 Added 141.92%
255,064 $19.9 Million
Q4 2021

Feb 14, 2022

SELL
$77.28 - $99.42 $2.66 Million - $3.42 Million
-34,430 Reduced 24.62%
105,433 $9.49 Million
Q3 2021

Nov 10, 2021

BUY
$65.97 - $92.48 $6.66 Million - $9.33 Million
100,935 Added 259.29%
139,863 $12.9 Million
Q2 2021

Jul 30, 2021

SELL
$69.38 - $86.75 $661,677 - $827,334
-9,537 Reduced 19.68%
38,928 $3.03 Million
Q1 2021

May 06, 2021

SELL
$72.25 - $168.95 $32.6 Million - $76.2 Million
-450,906 Reduced 90.29%
48,465 $3.61 Million
Q4 2020

Feb 08, 2021

BUY
$125.56 - $178.74 $4.67 Million - $6.65 Million
37,212 Added 8.05%
499,371 $85.1 Million
Q3 2020

Nov 12, 2020

SELL
$127.12 - $172.34 $6.62 Million - $8.98 Million
-52,100 Reduced 10.13%
462,159 $64.9 Million
Q2 2020

Aug 13, 2020

BUY
$93.0 - $171.7 $4.37 Million - $8.08 Million
47,031 Added 10.07%
514,259 $82.5 Million
Q1 2020

May 14, 2020

BUY
$82.38 - $131.64 $954,948 - $1.53 Million
11,592 Added 2.54%
467,228 $45.7 Million
Q4 2019

Feb 18, 2020

SELL
$76.53 - $135.58 $6.27 Million - $11.1 Million
-81,938 Reduced 15.24%
455,636 $58.8 Million
Q3 2019

Nov 14, 2019

BUY
$72.81 - $156.91 $3.13 Million - $6.74 Million
42,946 Added 8.68%
537,574 $40.5 Million
Q2 2019

Aug 14, 2019

SELL
$112.21 - $151.95 $8.96 Million - $12.1 Million
-79,807 Reduced 13.89%
494,628 $75.2 Million
Q1 2019

May 14, 2019

SELL
$106.67 - $151.68 $2.2 Million - $3.13 Million
-20,606 Reduced 3.46%
574,435 $68.5 Million
Q4 2018

Feb 13, 2019

BUY
$97.32 - $148.76 $31.5 Million - $48.2 Million
324,130 Added 119.64%
595,041 $64.9 Million
Q3 2018

Nov 08, 2018

SELL
$115.31 - $161.51 $14.6 Million - $20.5 Million
-126,744 Reduced 31.87%
270,911 $43.8 Million
Q2 2018

Aug 13, 2018

BUY
$71.74 - $153.69 $14.8 Million - $31.7 Million
206,455 Added 107.98%
397,655 $52.6 Million
Q1 2018

May 14, 2018

BUY
$54.02 - $82.27 $3.99 Million - $6.08 Million
73,860 Added 62.95%
191,200 $14.2 Million
Q4 2017

Feb 13, 2018

SELL
$47.64 - $56.75 $2.52 Million - $3 Million
-52,800 Reduced 31.03%
117,340 $6.53 Million
Q3 2017

Nov 13, 2017

BUY
$35.73 - $47.15 $6.08 Million - $8.02 Million
170,140
170,140 $7.72 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $8.51B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.